158 related articles for article (PubMed ID: 37534274)
1. Predictive value of the Framingham steatosis index for cardiovascular risk: a nationwide population-based cohort study.
Cho YK; Kim M; Kim YJ; Jung CH; Lee WJ; Park JY
Front Cardiovasc Med; 2023; 10():1163052. PubMed ID: 37534274
[TBL] [Abstract][Full Text] [Related]
2. Association of the atherogenic index of plasma with cardiovascular risk beyond the traditional risk factors: a nationwide population-based cohort study.
Kim SH; Cho YK; Kim YJ; Jung CH; Lee WJ; Park JY; Huh JH; Kang JG; Lee SJ; Ihm SH
Cardiovasc Diabetol; 2022 May; 21(1):81. PubMed ID: 35599307
[TBL] [Abstract][Full Text] [Related]
3. The Ability of the Framingham Steatosis Index (FSI) to Predict Non-alcoholic Fatty Liver Disease (NAFLD): A Cohort Study.
Motamed N; Nikkhah M; Karbalaie Niya MH; Khoonsari M; Perumal D; Ashrafi GH; Faraji AH; Maadi M; Ajdarkosh H; Safarnezhad Tameshkel F; Moradi-Lakeh M; Miri SM; Arsang-Jang S; Zamani F
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101567. PubMed ID: 33711631
[TBL] [Abstract][Full Text] [Related]
4. Fatty liver index and development of cardiovascular disease in Koreans without pre-existing myocardial infarction and ischemic stroke: a large population-based study.
Kim JH; Moon JS; Byun SJ; Lee JH; Kang DR; Sung KC; Kim JY; Huh JH
Cardiovasc Diabetol; 2020 May; 19(1):51. PubMed ID: 32359355
[TBL] [Abstract][Full Text] [Related]
5. The visceral adiposity index is a predictor of incident nonalcoholic fatty liver disease: A population-based longitudinal study.
Okamura T; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):375-383. PubMed ID: 32434704
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of the Framingham Steatosis Index to Identify Persons With Hepatic Steatosis.
Long MT; Pedley A; Colantonio LD; Massaro JM; Hoffmann U; Muntner P; Fox CS
Clin Gastroenterol Hepatol; 2016 Aug; 14(8):1172-1180.e2. PubMed ID: 27046482
[TBL] [Abstract][Full Text] [Related]
7. Compared to serum triglyceride alone, the association between serum triglyceride to high-density lipoprotein cholesterol ratio and 10-year cardiovascular disease risk as determined by Framingham risk scores in a large Korean cohort.
Lee HR; Kim JK; Kim JH; Chung TH
Clin Chim Acta; 2021 Sep; 520():29-33. PubMed ID: 34058221
[TBL] [Abstract][Full Text] [Related]
8. Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents.
Chin J; Mori TA; Adams LA; Beilin LJ; Huang RC; Olynyk JK; Ayonrinde OT
JHEP Rep; 2020 Dec; 2(6):100150. PubMed ID: 32984791
[TBL] [Abstract][Full Text] [Related]
9. Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women.
Liu PJ; Ma F; Lou HP; Zhu YN; Chen Y
Climacteric; 2014 Dec; 17(6):692-9. PubMed ID: 24884478
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. The association between triglyceride-glucose index, cardio-cerebrovascular diseases, and death in Korean adults: A retrospective study based on the NHIS-HEALS cohort.
Kim J; Shin SJ; Kang HT
PLoS One; 2021; 16(11):e0259212. PubMed ID: 34735502
[TBL] [Abstract][Full Text] [Related]
12. Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort.
Simon TG; Roelstraete B; Hagström H; Sundström J; Ludvigsson JF
Gut; 2022 Sep; 71(9):1867-1875. PubMed ID: 34489307
[TBL] [Abstract][Full Text] [Related]
13. The associations between changes in hepatic steatosis and heart failure and mortality: a nationwide cohort study.
Park J; Kim G; Kim H; Lee J; Jin SM; Kim JH
Cardiovasc Diabetol; 2022 Dec; 21(1):287. PubMed ID: 36564787
[TBL] [Abstract][Full Text] [Related]
14. Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease.
Cheng Y; Zhang Q; Li H; Zhou G; Shi P; Zhang X; Guan L; Yan F; Xu C
Front Endocrinol (Lausanne); 2023; 14():1098078. PubMed ID: 37214248
[TBL] [Abstract][Full Text] [Related]
15. Different effects of low muscle mass on the risk of non-alcoholic fatty liver disease and hepatic fibrosis in a prospective cohort.
Choe HJ; Lee H; Lee D; Kwak SH; Koo BK
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):260-269. PubMed ID: 36403577
[TBL] [Abstract][Full Text] [Related]
16. Skeletal muscle mass and abdominal obesity are independent predictors of hepatic steatosis and interact to predict ten-year cardiovascular disease incidence: Data from the ATTICA cohort study.
Kouvari M; Polyzos SA; Chrysohoou C; Skoumas J; Pitsavos CS; Panagiotakos DB; Mantzoros CS
Clin Nutr; 2022 Jun; 41(6):1281-1289. PubMed ID: 35504171
[TBL] [Abstract][Full Text] [Related]
17. Association between lipoprotein cholesterol and future cardiovascular disease and mortality in older adults: a Korean nationwide longitudinal study.
Kim SH; Son KY
Lipids Health Dis; 2021 Jan; 20(1):3. PubMed ID: 33407561
[TBL] [Abstract][Full Text] [Related]
18. Association between non-alcoholic fatty liver disease and risk of new-onset atrial fibrillation in healthy adults.
Roh JH; Lee JH; Lee H; Yoon YH; Kim M; Kim YG; Park GM; Park JH; Seong IW
Liver Int; 2020 Feb; 40(2):338-346. PubMed ID: 31479572
[TBL] [Abstract][Full Text] [Related]
19. Association of the cumulative triglyceride-glucose index with major adverse cardiovascular events in patients with type 2 diabetes.
Tai S; Fu L; Zhang N; Yang R; Zhou Y; Xing Z; Wang Y; Zhou S
Cardiovasc Diabetol; 2022 Aug; 21(1):161. PubMed ID: 35999546
[TBL] [Abstract][Full Text] [Related]
20. Impact of body mass index and body weight variabilities on mortality: a nationwide cohort study.
Nam GE; Cho KH; Han K; Han B; Cho SJ; Roh YK; Kim SM; Choi YS; Kim DH; Kim YH; Park YG
Int J Obes (Lond); 2019 Feb; 43(2):412-423. PubMed ID: 29777238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
